Clinical trial
Randomized, Controlled Trial With Hybrid Fractional Laser for Vulvovaginal Atrophy in Breast Cancer Survivors and Menopausal Females
NCT03647189 is registered in ClinicalTrials.gov with Sciton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Controlled Trial With Hybrid Fractional Laser for Vulvovaginal Atrophy in Breast Cancer Survivors and Menopausal Females
- Lead sponsor
- Sciton
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 10, 2018
- Completion date
- June 15, 2021
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vaginal atrophy, sexual dysfunction, vaginal dryness, dyspareunia